Strategic Management
Biocon – Term Paper

Name: Naresh.N

Section: B

Semester : 3rd

Batch : 2011-2013

PES Institute of Technology
2012

1/1/2012

INTRODUCTION

Industry Biotechnology
Founded 1978
Founder(s) Kiran Mazumdar-Shaw
Headquarters Bangalore, India
Biocon Limited (BSE: 532523) is a global biopharmaceutical company with products and research services ranging from pre-clinical to clinical development through to commercialization.[ref 1] Within biopharmaceuticals, the Company manufactures generic active pharmaceutical ingredients (APIs) like Statins and Immunosuppressants that are sold in the developed markets of the United States and Europe. It also manufactures biosimilar Insulins, which are sold in India as branded formulations and in both bulk and formulation forms.
Located with R & D in Bangalore and API unit in Hyderabad, India, Biocon has two subsidiaries— Syngene, a custom research organization, and Clinigene, a clinical research organization. Biocon’s presence straddles four main therapeutic areas—Diabetology, Cardiology, Nephrology and Oncology.
History
Biocon is a fully integrated healthcare company that delivers innovative biopharmaceutical solutions.
November 29, 1978 Biocon India is incorporated as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw.
1979—Becomes the first Indian company to manufacture and export enzymes to USA and Europe.
1989—Unilever plc. acquires Biocon Biochemicals Ltd. in Ireland and merges it with its subsidiary, Quest International; Biocon receives US funding for proprietary technologies.
1993—Biocon's R&D and manufacturing facilities receive ISO 9001 certification from RWTUV, Germany.
1998—Unilever agrees to sell its shareholding in Biocon to the Indian promoters. Biocon becomes an